Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary disease

Pulmonary Pharmacology and Therapeutics

Volumn 18, Issue 3, 2005, Pages 199-205

  Boschetto, Piera ^a,e   Miotto, Deborah ^a   Bononi, Ilaria ^a   Faggian, Diego ^b   Plebani, Mario ^b   Papi, Alberto ^a   Creminon, Christophe ^c   De Rosa, Edoardo ^a   Fabbri, Leonardo M ^d   Mapp, Cristina E ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Inst Natl Sci Appliques de Rouen   (France)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e Dipartimento di Medicina Clinica e Sperimentale   (Italy)

Author keywords

COPD; COPD exacerbations; Neurokinin A; Sputum; Substance P; Tachykinins

Indexed keywords

NEUROKININ A; SUBSTANCE P;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPUTUM; SPUTUM ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 20844435291     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2004.12.006     Document Type: Article

References (35)

1. R. Uddman, R. Hakanson, A. Luts, and F. Sundler Distribution of neuropeptides in airways P.J. Barnes Autonomic innervation of the respiratory tract 1997 Harwood Academic London 21 37
2. J.M. Lundberg, K. Alving, and J.A. Karlsson Sensory neuropeptide involvement in animal models of airway irritation and of allergen-evoked asthma Am Rev Respir Dis 143 1991 1429 1430
3. R.A. Pauwels, A.S. Buist, and P.M. Calverley Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 163 2001 1256 1276
4. D.F. Rogers Motor control of airway goblet cells and glands Respir Physiol 125 2001 129 144
5. C.E. Mapp, D. Miotto, and F. Braccioni The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways Am J Respir Crit Care Med 161 2000 207 215
6. M. Tomaki, M. Ichinose, and M. Miura Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis Am J Respir Crit Care Med 151 1995 613 617
7. A. Luts, R. Uddman, and P. Alm Peptide-containing nerve fibers in human airways: distribution and coexistence pattern Int Arch Allergy Immunol 101 1993 52 60
8. P.H. Howarth, D.R. Springall, and A.E. Redington Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects Am J Respir Cell Mol Biol 13 1995 288 296
9. P. Chanez, D. Springall, and A.M. Vignola Bronchial mucosal immunoreactivity of sensory neuropeptides in severe airway diseases Am J Respir Crit Care Med 158 1998 985 990
10. A.A. Hislop, J. Wharton, and K.M. Allen Immunohistochemical localization of peptide-containing nerves in human airways: age-related changes Am J Respir Cell Mol Biol 3 1990 191 198
11. J.P. Lamb, and M.P. Sparrow Three-dimensional mapping of sensory innervation with substance P in porcine bronchial mucosa: comparison with human airways Am J Respir Crit Care Med 166 2002 1269 1281
12. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 136 1987 225 244
13. R. Rodriguez-Roisin Toward a consensus definition for COPD exacerbations Chest 117 suppl 2 2000 398S 401S
14. N.M. Siafakas, P. Vermeire, and N.B. Pride Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force Eur Respir J 8 1995 1398 1420
15. P.H. Quanjer, G.J. Tammeling, and J.E. Cotes Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society Eur Respir J Suppl 16 1993 5 40
16. J.E. Cotes, D.J. Chinn, and P.H. Quanjer Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of lung function tests, European community for steel and coal. Official Statement of the European Respiratory Society Eur Respir J Suppl 16 1993 41 52
17. P. Maestrelli, M. Saetta, and A. Di Stefano Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage Am J Respir Crit Care Med 152 1995 1926 1931
18. M.M. Kelly, V. Keatings, and R. Leigh Analysis of fluid-phase mediators Eur Respir J 37 2002 24s 39
19. P.J. Barnes Neurogenic inflammation in the airways Respir Physiol 125 2001 145 154
20. G. Piedimonte, M.M. Rodriguez, and K.A. King Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs Am J Physiol 277 1999 L831 L840
21. T.R. Bai, D. Zhou, and T. Weir Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases Am J Physiol 269 1995 L309 L317
22. R.A. Skidgel, S. Engelbrecht, and A.R. Johnson Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase Peptides 5 1984 769 776
23. D.B. Borson Roles of neutral endopeptidase in airways Am J Physiol 260 1991 L212 L225
24. D.M. McDonald Respiratory tract infections increase susceptibility to neurogenic inflammation in the rat trachea Am Rev Respir Dis 137 1988 1432 1440
25. D.J. Dusser, T.D. Djokic, and D.B. Borson Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals J Clin Invest 84 1989 900 906
26. P.R. Germonprè, G.R. Bullock, and B.N. Lambrecht Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells Eur Respir J 14 1999 776 782
27. P.J. Barnes, J.N. Baraniuk, and M.G. Belvisi Neuropeptides in the respiratory tract. Part I Am Rev Respir Dis 144 1991 1187 1198
28. K. Kwong, Z.X. Wu, M.L. Kashon, K.M. Krajnak, P.M. Wise, and L.Y. Lee Chronic smoking enhances tachykinin synthesis and airway responsiveness in guinea pigs Am J Respir Cell Mol Biol 25 2001 299 305
29. D.B. Borson, and D.C. Gruenert Glucocorticoids induce neutral endopeptidase in transformed human tracheal epithelial cells Am J Physiol 260 1991 L83 L89
30. J.K. Sont, J.H. van Krieken, and H.C. van Klink Enhanced expression of neutral endopeptidase (NEP) in airway epithelium in biopsies from steroid- versus nonsteroid-treated patients with atopic asthma Am J Respir Cell Mol Biol 16 1997 549 556
31. D. Proud, M.C. Subauste, and P.E. Ward Glucocorticoids do not alter peptidase expression on a human bronchial cell line Am J Respir Cell Mol Biol 11 1994 57 65
32. V.H. Van Der Velden, B.A. Naber, and P.T. Van Hal Peptidase activities in serum and bronchoalveolar lavage fluid from allergic asthmatics-comparison with healthy non-smokers and smokers and effects of inhaled glucocorticoids Clin Exp Allergy 29 1999 813 823
33. S.L. Ollerenshaw, D. Jarvis, and C.E. Sullivan Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics Eur Respir J 4 1991 673 682
34. C.M. Lilly, T.R. Bai, and S.A. Shore Neuropeptide content of lungs from asthmatic and nonasthmatic patients Am J Respir Crit Care Med 151 1995 548 553
35. R.E. Lucchini, F. Facchini, and G. Turato Increased VIP-positive nerve fibers in the mucous glands of subjects with chronic bronchitis Am J Respir Crit Care Med 156 1997 1963 1968